EZH2 and neoplasm: Beyond T-cell modulation, EZH2 inhibition also enhances the cytotoxic activity of natural killer (NK) cells by upregulating activating ligands, such as NKG2D ligands, thereby bolstering innate immune responses against the tumor [201].